Decreasing childhood pertussis infection through vaccination of the elderly

Tanner W Higginbotham1, Kevin W Cleveland

  • 1Idaho State University College of Pharmacy, Pocatello, ID 83209-8092, USA.

Insights

Reported pertussis (whooping cough) cases are rising in infants and adolescents, alongside infant deaths. Vaccinating older adults could prevent transmission to children, but current vaccines aren

Area of Science:

  • * Public Health
  • * Infectious Diseases
  • * Immunology

Background:

  • * Increasing pertussis (whooping cough) incidence observed in infants and adolescents.
  • * Rising infant mortality rates linked to pertussis infections caused by Bordetella pertussis.
  • * Adults, particularly those aged 65 and older, are significant vectors for pertussis transmission due to waning immunity.

Purpose of the Study:

  • * To evaluate the potential public health benefit of recommending the Tdap vaccine for individuals aged 64 and older.
  • * To assess the role of older adults in the transmission cycle of pertussis to vulnerable pediatric populations.

Main Methods:

  • * Review of epidemiological data on pertussis incidence and mortality in infants and adolescents.
  • * Analysis of the role of adult populations, specifically those 65 years and older, as transmission vectors.
  • * Examination of evidence regarding waning immunity post-infection or vaccination in adults.

Main Results:

  • * Pertussis cases and associated infant deaths are increasing.
  • * Older adults represent a substantial pool for pertussis transmission.
  • * Immunity wanes in adults after infection or vaccination, increasing susceptibility and transmission potential.

Conclusions:

  • * Recommending the Tdap vaccine for individuals 64 years and older could significantly benefit public health by reducing pertussis transmission to children.
  • * Current Tdap vaccines are not licensed for individuals over 65, and no off-label recommendations exist from the CDC's Advisory Committee on Immunization Practices for this age group.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...